Compare Stocks: WNW, NATR, NAGE, and MED

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MED Medifast	$11.89 -1.4%	$11.91	$9.22 ▼ $13.58	$132.83M	0.68	125,922 shs	94,140 shs
NAGE Niagen Bioscience	$2.49 -3.5%	$2.98	$2.46 ▼ $7.95	$198.31M	2.02	564,955 shs	555,781 shs
NATR Nature's Sunshine Products	$12.64	$13.60	$12.00 ▼ $28.14	$222.41M	0.81	112,419 shs	95,148 shs
WNW Meiwu Technology	$2.14 +2.9%	$2.42	$2.01 ▼ $1,352.00	$56.35M	0.85	130,017 shs	49,462 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MED Medifast	0.00%	+2.41%	-0.56%	+15.95%	-9.38%
NAGE Niagen Bioscience	0.00%	-7.43%	-16.72%	-24.09%	-66.80%
NATR Nature's Sunshine Products	0.00%	0.00%	-3.44%	-38.13%	-14.94%
WNW Meiwu Technology	0.00%	0.00%	-8.94%	-35.15%	-98.85%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
MED Medifast	$11.89 -1.4%	$11.91	$9.22 ▼ $13.58	$132.83M	0.68	125,922 shs	94,140 shs
NAGE Niagen Bioscience	$2.49 -3.5%	$2.98	$2.46 ▼ $7.95	$198.31M	2.02	564,955 shs	555,781 shs
NATR Nature's Sunshine Products	$12.64	$13.60	$12.00 ▼ $28.14	$222.41M	0.81	112,419 shs	95,148 shs
WNW Meiwu Technology	$2.14 +2.9%	$2.42	$2.01 ▼ $1,352.00	$56.35M	0.85	130,017 shs	49,462 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
MED Medifast	0.00%	+2.41%	-0.56%	+15.95%	-9.38%
NAGE Niagen Bioscience	0.00%	-7.43%	-16.72%	-24.09%	-66.80%
NATR Nature's Sunshine Products	0.00%	0.00%	-3.44%	-38.13%	-14.94%
WNW Meiwu Technology	0.00%	0.00%	-8.94%	-35.15%	-98.85%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
MED Medifast	2.33	Hold	$12.00	0.93% Upside
NAGE Niagen Bioscience	3.00	Buy	$10.33	314.99% Upside
NATR Nature's Sunshine Products	2.67	Moderate Buy	$30.50	141.30% Upside
WNW Meiwu Technology	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest WNW, NATR, NAGE, and MED Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	NAGE Niagen Bioscience	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Hold (C)
10/13/2026	MED Medifast	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
8/18/2026	NATR Nature's Sunshine Products	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C+) ➝ Hold (C)
8/17/2026	MED Medifast	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D)
8/11/2026	MED Medifast	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Strong-Buy ➝ Hold
8/10/2026	NATR Nature's Sunshine Products	DA Davidson Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$33.00 ➝ $25.00
8/5/2026	NAGE Niagen Bioscience	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy
8/5/2026	NAGE Niagen Bioscience	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$10.00
8/3/2026	MED Medifast	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
7/31/2026	WNW Meiwu Technology	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
7/30/2026	NATR Nature's Sunshine Products	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$37.00 ➝ $36.00

(Data available from 10/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
MED Medifast	$385.79M	0.34	$0.42 per share	28.62	$18.10 per share	0.66
NAGE Niagen Bioscience	$129.08M	1.54	$0.20 per share	12.28	$0.96 per share	2.59
NATR Nature's Sunshine Products	$492.02M	0.45	$2.18 per share	5.81	$9.23 per share	1.37
WNW Meiwu Technology	$7.08M	7.96	N/A	N/A	$315.76 per share	0.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
MED Medifast	-$18.67M	-$2.33	N/A	N/A	N/A	-8.08%	-6.69%	-5.25%	10/26/2026 (Confirmed)
NAGE Niagen Bioscience	$17.38M	$0.18	13.83	27.67	N/A	12.39%	17.95%	13.17%	N/A
NATR Nature's Sunshine Products	$19.52M	$1.01	12.51	N/A	N/A	3.68%	12.88%	8.17%	11/9/2026 (Estimated)
WNW Meiwu Technology	-$18.59M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest WNW, NATR, NAGE, and MED Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/9/2026	Q3 2026	NATR Nature's Sunshine Products	$0.2650	N/A	N/A	N/A	$129.50 million	N/A
10/26/2026	Q3 2026	MED Medifast	-$0.35	N/A	N/A	N/A	$71.30 million	N/A
8/6/2026	Q2 2026	NATR Nature's Sunshine Products	$0.27	$0.21	-$0.06	$0.19	$123.70 million	$116.99 million
8/4/2026	Q2 2026	NAGE Niagen Bioscience	$0.01	$0.01	N/A	$0.01	$29.95 million	$29.78 million
8/3/2026	Q2 2026	MED Medifast	-$0.65	-$0.28	+$0.37	-$0.28	$72.70 million	$76.38 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
MED Medifast	N/A	N/A	-100.00%	N/A	N/A
NAGE Niagen Bioscience	N/A	N/A	N/A	N/A	N/A
NATR Nature's Sunshine Products	$0.40	3.16%	N/A	39.60%	N/A
WNW Meiwu Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
MED Medifast	N/A	4.86	4.35
NAGE Niagen Bioscience	N/A	6.50	5.13
NATR Nature's Sunshine Products	N/A	2.60	1.55
WNW Meiwu Technology	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
MED Medifast	95.51%
NAGE Niagen Bioscience	15.41%
NATR Nature's Sunshine Products	79.40%
WNW Meiwu Technology	0.29%

Insider Ownership

Company	Insider Ownership
MED Medifast	3.70%
NAGE Niagen Bioscience	10.00%
NATR Nature's Sunshine Products	3.10%
WNW Meiwu Technology	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
MED Medifast	380	11.18 million	10.77 million	Optionable
NAGE Niagen Bioscience	117	79.64 million	71.68 million	N/A
NATR Nature's Sunshine Products	806	17.60 million	17.05 million	Optionable
WNW Meiwu Technology	92	26.33 million	N/A	N/A

WNW, NATR, NAGE, and MED Headlines

Recent News About These Companies

Meiwu Technology discloses going-concern doubt for Meiwu Technology stock

October 15 at 7:49 PM | ad-hoc-news.deA

Meiwu Technology stock completes Hemeitong acquisition

October 7, 2026 | ad-hoc-news.deA

Meiwu Technology stock completes 100 percent acquisition deal

September 30, 2026 | ad-hoc-news.deA

Meiwu Technology stock completes 100 percent acquisition

September 29, 2026 | ad-hoc-news.deA

Meiwu Technology Completes RMB235 Million Acquisition of Xiamen Hemeitong

September 23, 2026 | tipranks.com

Meiwu Technology Shareholders Approve Dual-Class Structure and Governance Changes

September 15, 2026 | tipranks.com

Meiwu Technology (WNW) stock soars 48% after hours: Here's what you need to know

August 27, 2026 | msn.com

Meiwu Technology Moves to Acquire Xiamen Hemeitong to Boost AI Skincare Platform

August 26, 2026 | tipranks.com

Meiwu Technology Calls September Extraordinary Meeting to Approve Dual-Class Share Structure

August 11, 2026 | tipranks.com

Meiwu Technology Completes July Disposition of BVI Subsidiary for Nominal Sum

July 29, 2026 | tipranks.com

Meiwu Technology Sheds Defunct SMS Subsidiary in Liability-Reducing Sale

July 9, 2026 | tipranks.com

Why Is Meiwu Stock Surging Wednesday?

May 20, 2026 | benzinga.com

Meiwu Technology Co Stock Short Interest Report | NASDAQ:WNW | Benzinga

May 20, 2026 | benzinga.com

What's going on with Meiwu Technology stock today?

May 19, 2026 | msn.com

What's Going On With Meiwu Technology Stock Today?

May 19, 2026 | benzinga.com

Meiwu Technology (WNW) more than doubles amid micro-cap volatility after reverse split and fresh capital raise

May 19, 2026 | quiverquant.comQ

Meiwu Technology Raises $15.65 Million in PIPE to Fund AI Skincare Platform

May 15, 2026 | theglobeandmail.com

Insider Buying: Meiwu Technology (NASDAQ:WNW) Major Shareholder Purchases 3,069 Shares of Stock

May 12, 2026 | insidertrades.com

Meiwu Technology Company Limited Announces 1-For-100 Reverse Share Split

April 1, 2026 | prnewswire.com

Meiwu Technology Raises $14 Million in Registered Direct Offering With One-Year Warrants

March 19, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

WNW, NATR, NAGE, and MED Company Descriptions

Medifast NYSE:MED

$11.89 -0.17 (-1.41%)

Closing price 10/16/2026 03:59 PM Eastern

Extended Trading

$11.89 0.00 (0.00%)

As of 10/16/2026 07:30 PM Eastern

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Niagen Bioscience NASDAQ:NAGE

$2.49 -0.09 (-3.49%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$2.50 +0.01 (+0.40%)

As of 10/16/2026 07:44 PM Eastern

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Nature's Sunshine Products NASDAQ:NATR

$12.64 0.00 (0.00%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$12.60 -0.04 (-0.28%)

As of 10/16/2026 07:30 PM Eastern

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Meiwu Technology NASDAQ:WNW

$2.14 +0.06 (+2.88%)

Closing price 10/16/2026 04:00 PM Eastern

Extended Trading

$2.15 +0.01 (+0.70%)

As of 10/16/2026 07:48 PM Eastern

Wunong Net Technology Company Limited, a holding company, engages in the online retail of foods products in China. The company offers green food, organic food, intangible cultural heritage food, agricultural products, and pollution-free products. It also operates a restaurant under the Wunong Food Hall name; and engages in the wholesale of agricultural products. The company was formerly known as Advancement International Limited and changed its name to Wunong Net Technology Company Limited in August 2019. Wunong Net Technology Company Limited was incorporated in 2018 and is headquartered in Shenzhen, the People's Republic of China.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest WNW, NATR, NAGE, and MED Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest WNW, NATR, NAGE, and MED Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

WNW, NATR, NAGE, and MED Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

WNW, NATR, NAGE, and MED Company Descriptions

Medifast NYSE:MED

Niagen Bioscience NASDAQ:NAGE

Nature's Sunshine Products NASDAQ:NATR

Meiwu Technology NASDAQ:WNW

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest WNW, NATR, NAGE, and MED Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest WNW, NATR, NAGE, and MED Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

WNW, NATR, NAGE, and MED Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

WNW, NATR, NAGE, and MED Company Descriptions

Medifast NYSE:MED

Niagen Bioscience NASDAQ:NAGE

Nature's Sunshine Products NASDAQ:NATR

Meiwu Technology NASDAQ:WNW

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools